RPRX CIK: 1802768

Royalty Pharma plc

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
2.27
FY22:
–
FY23:
–
FY24:
–
FY25:
2.29
(positive)
Change from FY21 to FY25
billions USD
FY21:
1.43
FY22:
0.31
FY23:
1.49
FY24:
1.29
FY25:
1.56
(positive)
Change from FY21 to FY25
billions USD
FY21:
1.48
FY22:
–
FY23:
1.57
FY24:
1.37
FY25:
1.61
(positive)
Change from FY21 to FY25
billions USD
FY21:
1.24
FY22:
0.23
FY23:
1.70
FY24:
1.33
FY25:
1.32
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.62
FY22:
0.04
FY23:
1.13
FY24:
0.86
FY25:
0.77

All amounts in billions USD Data sources:SEC EDGARTwelve Data